BusinessAxsome Therapeutics to Present at the 29th Annual ROTH ConferenceBy Nasdaq OMXFeb 27, 2017, 12:00 PM UTC
BusinessEntia Biosciences, Inc. (OTCQB: ERGO) Enters into Exclusive Worldwide Licensing Agreement for its GROH Beauty Products LineBy Nasdaq OMXFeb 24, 2017, 9:01 PM UTC
BusinessAchillion Reports 2016 Fourth Quarter and Year-End Financial ResultsBy Nasdaq OMXFeb 23, 2017, 9:05 PM UTC
BusinessRedHill Biopharma Announces Availability of Its Annual Report on Form 20-F Through Its WebsiteBy Nasdaq OMXFeb 23, 2017, 3:07 PM UTC
BusinessColby Underwood, Co-Chief Executive Officer / Chief Business Officer for Blue Marble Biomaterials, is Featured in a New Exclusive Interview with SmallCapVoice.comBy Nasdaq OMXFeb 23, 2017, 1:03 PM UTC
BusinessColby Underwood, Co-Chief Executive Officer / Chief Business Officer for Blue Marble Biomaterials, is Featured in a New Exclusive Interview with SmallCapVoice.comBy Nasdaq OMXFeb 23, 2017, 1:02 PM UTC
BusinessColby Underwood, Co-Chief Executive Officer / Chief Business Officer for Blue Marble Biomaterials, is Featured in a New Exclusive Interview with SmallCapVoice.comBy Nasdaq OMXFeb 23, 2017, 1:02 PM UTC
BusinessFibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXFeb 23, 2017, 1:01 PM UTC
